Company: ATRA
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0000950170-25-035507
Chunk: 195

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 1B
Chunk 195
---
 items, net

    (402
    )

    214

    Changes in operating assets and liabilities:

    Accounts receivable

    32,626

    6,113

    Inventories

    (4,434
    )

    (8,120
    )

    Other current assets

    (1,227
    )

    273

    Other assets

    19

    1,043

    Accounts payable

    687

    (3,130
    )

    Accrued compensation

    (4,930
    )

    (6,140
    )

    Accrued research and development expenses

    (9,380
    )

    (3,663
    )

    Other current liabilities

    (12,504
    )

    11,064

    Deferred revenue

    (20,303
    )

    30,395

    Operating lease liabilities

    (11,051
    )

    (12,636
    )

    Other long-term liabilities

    (462
    )

    142

    Net cash used in operating activities

    (68,717
    )

    (192,977
    )

    Investing activities

    Purchases of short-term investments

    (19,665
    )

    (83,648
    )

    Proceeds from maturities and sales of short-term investments

    28,535

    208,712

    Purchases of property and equipment

    (246
    )

    (1,223
    )

    Proceeds from sale of property and equipment

    —

    25

    Net cash provided by (used in) investing activities

    8,624

    123,866

    Financing activities

    Proceeds from sale of common stock and pre-funded warrants in  registered direct offerings, net

    50,603

    —

    Proceeds from issuance of common stock through ATM facilities, net

    9,348

    2,136

    Proceeds from employee stock awards

    230

    928

    Taxes paid related to net share settlement of restricted stock units

    —

    (94
    )

    Principal payments on finance lease obligations

    (892
    )

    (947
    )

    Other financing activities, net

    (7
    )

    (13
    )

    Net cash provided by financing activities